Elanco Animal Health Inc. general counsel and corporate secretary Michael-Bryant Hicks will leave the company to join Apria Healthcare Group, Inc., as executive vice president and general counsel.
Hicks joined Indianapolis-based Elanco in 2018 from Mallinckrodt Pharmaceuticals, where he worked for two years as senior vice president and general counsel. Hicks confirmed his move to Apria to Bloomberg Law this week said he will begin his new role at the medical device company on March 15.
Hicks led Elanco’s legal team through its 2018 IPO and subsequent split from former parent company Eli Lilly and Co., as well as the company’s $6.9 billion acquisition of Bayer AG’s animal health unit last fall.
Apria Healthcare went public on Feb. 10 and specializes in home respiratory services and medical equipment. Hicks said the company has around $1 billion in annual revenue and hopes to continue growing following its recent IPO.
“My decision to leave [Elanco] is about opportunities at Apria,” Hicks said, noting that Apria will give him the chance to help set up another public company and assist in potential future acquisitions. “This is a big transformation story, and I’m excited to be a part of it.”
Elanco is already seeking Hicks’ replacement, according to a Feb. 22 company statement. Hicks said Elanco has recruited Catherine Powell as interim general counsel following his departure.
Before his time with Elanco, Hicks worked for social services provider The Providence Service Corp., manufacturing company Beckman Coulter, and healthcare company DaVita, Inc. He started his career in private practice with Vinson & Elkins and Mayer Brown.
Since acquiring Bayer Animal Health, Elanco has announced multiple restructuring plans including the elimination of over 900 jobs globally in departments such as marketing, research and development, and manufacturing.
Elanco also pledged an additional 570 jobs over 10 years in Indiana, the recently announced headquarters of the company’s future global operations site.
Hicks said his decision to leave was unrelated to these restructuring efforts.
Elanco reported a net loss of $135 million for the third quarter of 2020, compared to a net income of $10 million for the same quarter in 2019. In the company’s Nov. 6 earnings report, it partially attributed the loss to less activity in the farm animal business due to the pandemic’s impact on agriculture.
“Although improvements were made in reducing the backlog of animal processing in the U.S. livestock industry, unfavorable macroeconomic conditions and reduced consumption trends pressured prices and producer profitability in both poultry and aqua, impacting Elanco’s international business,” Elanco said in the report.
Elanco’s former deputy general counsel Darlene Quashie Henry also left the company last month after two years. She is now vice president, associate general counsel, and corporate secretary at tobacco company Philip Morris International, according to a recent Philip Morris securities filing.